Some of the world’s most exciting companies are still private.
SpaceX.
OpenAI.
Anthropic.
Stripe.
Databricks.
They dominate headlines, attract elite investors and carry huge private-market valuations.
But for ordinary investors, one question is hard to answer:
Are these companies actually worth the price being quoted?
A private valuation is not the same as a public stock-market price.
It may come from a funding round.
It may come from secondary-market trading.
It may reflect scarcity, investor demand, hype and future expectations.
That does not mean the valuation is wrong.
But it does mean investors need a way to decode it.
That is why Decentralised News built the DN Pre-IPO Valuation Decoder.
It turns a headline private valuation into a practical fundamentals check.
A private company valuation is usually based on its latest funding round or secondary-market share price.
To judge whether that valuation is reasonable, compare it with revenue and public-market peers.
The key metric is:
Revenue multiple = valuation divided by annual revenue
A company growing faster than public peers may deserve a higher multiple.
A company growing slower may deserve a lower multiple.
The DN Pre-IPO Valuation Decoder calculates:
Implied revenue multiple
Growth-adjusted peer multiple
Premium to justified valuation
Future dilution impact
Years needed to grow into the valuation
DN IPO Reality Score
A high score means the valuation is more grounded in fundamentals.
A low score means the valuation depends heavily on future execution.
Useful exposure and research platforms include:
Bybit, code 46164, for selected pre-IPO or tokenized exposure where available
OKX, code 2136301, for tokenized-equity and derivatives access where supported
Gate.com, for broad tokenized market access
MEXC, code 16yJL, for active market access
TradingView, for charting listed comparables
Pre-IPO and tokenized-equity products are high risk and may not be available in every region.
Use the DN Pre-IPO Valuation Decoder to estimate whether a private company valuation is grounded in current fundamentals or priced mainly on future growth. Enter valuation, revenue, growth rate, sector peer multiple and expected dilution to generate the DN IPO Reality Score.
Do not judge a private company by headline valuation alone. Compare valuation to revenue, growth, dilution and listed public peers before assuming the price is fair.
A public stock price is created by continuous buying and selling.
A private valuation is different.
It is often based on a funding round where a small group of investors buys a small portion of the company.
That price is then multiplied across all shares to create a headline valuation.
This can be useful.
But it can also be misleading.
Private valuations can reflect:
Scarcity
Momentum
Brand power
Investor competition
Strategic value
Future growth expectations
Late-stage funding dynamics
Secondary-market demand
The result is a number that may be real, but not necessarily liquid, tested or fairly priced by a broad market.
That is why pre-IPO valuation analysis matters.
The simplest way to decode a private valuation is to compare it with revenue.
Formula:
Revenue multiple = valuation ÷ annual revenue
Example:
Private valuation: $100 billion
Annual revenue: $5 billion
Revenue multiple: 20x
That means investors are valuing the company at 20 times annual revenue.
This may be reasonable for a hyper-growth category leader.
It may be extreme for a slower-growth company.
The number only makes sense when compared with public peers.
A company growing revenue at 100% per year deserves a different valuation framework than one growing at 15%.
Fast growth can justify a higher multiple because the company may grow into its valuation quickly.
Slow growth makes high multiples harder to defend.
That is why the DN model compares the company’s growth rate with sector peer growth.
The question is not only:
What multiple is the company trading at?
The better question is:
Is the multiple justified by growth compared with public companies in the same sector?
The comparables method looks at similar listed companies and asks what the public market is paying for them.
For example:
AI software companies may be compared with listed software and AI infrastructure peers.
Space or aerospace companies may be compared with listed aerospace, defence or launch-related firms.
Fintech companies may be compared with listed payments and financial technology businesses.
Cloud and data companies may be compared with listed cloud infrastructure and data platform companies.
The decoder uses a peer revenue multiple, then adjusts it for growth.
Simplified formula:
Justified multiple = peer multiple × growth adjustment
Then it compares the private company’s effective multiple with that justified multiple.
That gap is the premium.
The larger the premium, the more future expectation is baked into the price.
Private investors often forget dilution.
Before a company goes public, it may issue more shares for:
New funding rounds
Employee stock compensation
Option pools
Convertible instruments
Strategic investors
IPO-related share creation
Dilution means your ownership percentage can shrink.
Even if the company grows, more shares can reduce the value of each existing share.
That is why the DN tool lets users include expected dilution.
A valuation that looks acceptable before dilution may look more stretched after dilution.
The DN IPO Reality Score is a 0 to 100 score that estimates how grounded a private valuation is.
It compares:
Current valuation
Annual revenue
Revenue growth
Sector peer multiple
Expected dilution
Growth-adjusted justified multiple
The score does not predict IPO performance.
It does not say whether a company is good or bad.
It simply shows how much of the valuation is supported by fundamentals versus future expectation.
The valuation is close to what comparable public companies may justify based on revenue and growth.
Best interpretation:
More fundamentals-driven
Less hype-dependent
Still needs due diligence
Potentially more defensible
The company trades at a growth premium, but the premium may be explainable.
Best interpretation:
Strong company expectations
Some future success priced in
Not cheap, but not detached
Execution still matters
The valuation already assumes strong future growth.
Best interpretation:
Significant execution risk
Public-market repricing possible
Needs sustained growth
Not enough to rely on brand alone
The valuation depends heavily on future transformation.
Best interpretation:
High expectation
High risk
Big upside only if growth continues
Weak margin for disappointment
The valuation is far beyond what current revenue and comparable public multiples can justify.
Best interpretation:
Mostly future narrative
Extremely execution-dependent
High repricing risk
Requires major business expansion
One of the most useful outputs is:
How many years does the company need to grow into its valuation?
This makes the valuation easier to understand.
Instead of saying:
“This company trades at a very high revenue multiple.”
The tool asks:
“At its current growth rate, how many years of uninterrupted execution are needed before this valuation looks normal?”
That is a better question.
A company that needs one or two years of strong growth to justify its price may be reasonable.
A company that needs five to ten years of flawless growth may be priced for perfection.
Pre-IPO investing can sound exciting because investors want access before the public listing.
But the risks are real.
Pre-IPO and tokenized-equity products may carry:
Liquidity risk
Counterparty risk
Tracking risk
Pricing risk
Regulatory risk
Access restrictions
Lockup complications
Unverified financial data
Limited disclosure
No guarantee of IPO timing
A product may reference a private company without giving the same rights as direct equity ownership.
Always understand what you are buying.
There are several possible routes.
This is the cleanest route for most investors.
Once a company lists publicly, investors can buy shares through traditional brokers.
The benefit is better disclosure and clearer market pricing.
The drawback is that early upside may already be priced in.
Some crypto platforms may offer pre-IPO perpetuals or tokenized-equity products where available.
These can provide exposure before a public listing, but they are more complex and may not represent direct ownership.
Sometimes the smarter trade is not buying the private company directly.
It may be buying listed companies that benefit from the same theme.
For example:
AI infrastructure
Semiconductors
Cloud software
Aerospace
Payments
Cybersecurity
Data platforms
This gives thematic exposure with more transparency.
Use public comps to understand how the market values the category.
Then compare the IPO price with those comps when the company eventually lists.
This helps avoid buying at any price just because the brand is famous.
Bybit may offer selected pre-IPO, tokenized or derivatives-style exposure depending on region and availability.
Use code 46164.
Best for:
Active traders
Tokenized market access
Derivatives exposure
Pre-IPO-style products where supported
High-liquidity trading
OKX offers a broad trading ecosystem, including spot, derivatives, Web3 and selected tokenized products where available.
Use code 2136301.
Best for:
Active crypto users
Tokenized exposure
Derivatives trading
Web3 tools
Liquidity access
Gate.com is useful for broad market access and selected tokenized or early-market products where available.
Best for:
Broad listings
Early-market access
Altcoin and tokenized products
Active traders
MEXC is useful for active traders looking for wide market access.
Use code 16yJL.
Best for:
Broad market coverage
Active trading
Early listings
Tokenized exposure where supported
TradingView is useful for charting public comparables before judging a private valuation.
Best for:
Sector analysis
Comparables research
Charting listed companies
Valuation context
Public market trend tracking
Before buying any pre-IPO or tokenized exposure, ask:
What is the latest valuation?
How reliable is the revenue estimate?
What is the implied revenue multiple?
How fast is the company growing?
What do public peers trade at?
Is the valuation growth-adjusted or purely narrative-driven?
How much future dilution is likely?
How many years of growth are needed to justify the price?
What product am I actually buying?
Does it represent direct equity or synthetic exposure?
Can I exit easily?
Is it legal and available in my region?
If you cannot answer these questions, position size should be small or zero.
A great company can still be a bad investment if the entry price is too high.
Narrative matters, but revenue is what helps ground valuation.
Future share issuance can weaken investor returns.
An AI company should not be valued against slow-growth industrials.
A fintech should not be valued against software peers without adjustment.
Always check the product structure.
Some instruments track price exposure without giving the same rights as owning shares.
The public market can reprice famous companies quickly if growth disappoints.
The best strategy is not to chase every private-market headline.
Use the decoder first.
Compare valuation to revenue.
Compare revenue multiple to peers.
Adjust for growth.
Include dilution.
Estimate years needed to grow into the valuation.
Then decide whether the exposure is worth the risk.
A famous private company may be brilliant.
But the investment question is always:
At what price?
Suggested internal links:
IPO Lockup and Day-One Pop Calculator
Private Unicorn Tracker
Pre-IPO Access Router
Tokenized Stocks Guide
Store-of-Value Comparator
Crypto Portfolio Allocation Tool
Use these tools together:
The Pre-IPO Valuation Decoder checks whether the price is reasonable.
The IPO Lockup Calculator models listing-day supply pressure.
The Private Unicorn Tracker monitors likely IPO candidates.
The Pre-IPO Access Router compares ways to get exposure.
The Tokenized Stocks Guide explains product structure and risk.
Bybit
Best for active traders, tokenized exposure and derivatives-style products where available. Use code 46164.
OKX
Best for spot, derivatives, Web3 and tokenized market access where supported. Use code 2136301.
Gate.com
Best for broad early-market and tokenized product access where available.
MEXC
Best for broad market access and active trading. Use code 16yJL.
TradingView
Best for charting public comparables and building a valuation view before investing.
SpaceX, OpenAI, Anthropic, Stripe and Databricks may become some of the defining companies of the next decade.
But even great companies can be overpriced.
A headline valuation does not tell investors whether the price is grounded.
The DN Pre-IPO Valuation Decoder helps turn private-market hype into a structured question:
How much revenue does the company have?
How fast is it growing?
What do public peers trade at?
How much dilution is coming?
How many years of growth are needed to justify the price?
That is how serious investors think.
Not “is this company exciting?”
But:
Is the price already assuming perfection?
Use the tool before chasing the next private-market headline.
Their private valuations depend on the latest funding round, secondary-market trades and reported financials. Use the DN Pre-IPO Valuation Decoder to compare valuation with estimated revenue, peer multiples and growth.
A common method is to divide valuation by annual revenue, then compare the revenue multiple with similar public companies after adjusting for growth.
The DN IPO Reality Score is a 0 to 100 score that estimates how grounded a private company valuation is in fundamentals versus future expectation.
Some investors may access pre-IPO or tokenized exposure through selected platforms, but availability depends on region and product structure. These products can carry high counterparty, liquidity, tracking and regulatory risk.
Private valuations can be driven by scarcity, investor demand, category leadership, growth expectations and limited market pricing. They are not always tested by broad public-market liquidity.
Revenue multiple means valuation divided by annual revenue. A company valued at $100 billion with $5 billion in revenue trades at 20x revenue.
It estimates how many years a company must keep growing before its revenue could justify the current valuation at a normal public-market peer multiple.
Not necessarily. A high valuation may be justified if growth, margins and category dominance are exceptional. But it leaves less room for disappointment.
Risks include liquidity risk, counterparty risk, tracking error, unclear ownership rights, regulatory restrictions and limited financial disclosure.
Beginners should be cautious. Pre-IPO and tokenized products are complex and may not be suitable without understanding valuation, liquidity and product structure.
This article is for educational purposes only and does not constitute financial, investment, legal or tax advice. Private-company financials are often estimated, unverified and outdated. The DN IPO Reality Score is a simplified model and not a valuation opinion. Pre-IPO and tokenized-equity products carry significant risks and may be restricted in your jurisdiction. Some links are affiliate links and may support Decentralised News at no extra cost to the reader.